益方生物 InventisBio
Founded 2013
China
30 employees
Series D
Total: $247.00M
Biopharma, Biotechnology +1
China
30 employees
Series D
Total: $247.00M
Biopharma, Biotechnology +1
General Information
Get notified when 益方生物 InventisBio moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track 益方生物 InventisBio
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
China Market
Biopharma
About 益方生物 InventisBio
Funding Rounds & Investors (4)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series D | •••••• | 10 |
|
27 Sep 2020 |
| Series C | •••••• | - | 12 Mar 2019 | |
| Series B | •••••• | - | 30 May 2017 | |
| Series A | •••••• | - | 01 Jan 2016 |
FAQ About 益方生物 InventisBio
益方生物科技（上海）有限公司是一家成立于2013年的创业型生物医药公司，致力于肿瘤，肿瘤免疫，代谢领域的新药研发，公司产品管线已包含肺癌、乳腺癌，肿瘤免疫和痛风等领域靶向治疗的小分子候选药物，同时公司也在积极开发其他肿瘤及免疫肿瘤靶点的药物。公司目前有四个自主研发的1类新药，分别在中、美两地进行临床一、...
益方生物 InventisBio was founded in 2013.
益方生物 InventisBio is headquartered in China.
益方生物 InventisBio operates in the following industries: Biopharma, Biotechnology, Pharmaceutical.
益方生物 InventisBio has approximately 30 employees.
益方生物 InventisBio has completed 4 funding rounds, raising a total of $247.00M. The latest funding stage is Series D.
We're actively collecting intelligence on 益方生物 InventisBio.
Track 益方生物 InventisBio to get notifiedDon't just browse. Track.
Signal Tracker monitors 益方生物 InventisBio and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.
